A Phase I/II Study of Dose Escalated Intensity Modulated Radiation Therapy for the Treatment of Pelvic Lymph Nodes and Primary Tumour in Patients with Carcinoma of the Prostate.
This is a single institution prospective phase I-II
study. All eligible patients with high risk prostate cancer who are going
to have primary radiation therapy to the pelvic lymph nodes and prostate
seminal vesicles with or without concurrent hormonal therapy will be approached
regarding study entry.
Patients will be treated supine with an intensity modulated
radiation therapy treatment plan. Patients will be planned using inverse
planning techniques to maximize the dose to the CTV and minimize the dose to
bladder and rectal walls, and femoral heads.
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society